Natural history of self-reported symptoms following SARS-CoV-2 infection: A target trial emulation in a prospective community-recruited cohort

Authors:

Abstract
No abstract available
Funding Information
  • Pfizer
  • Division of Intramural Research (UH3AI133675)
  • National Institutes of Health
  • City University of New York
  • National Institute of Allergy and Infectious Diseases

This publication has 38 references indexed in Scilit: